References- Cell
Cycle
- Pumin Zhang The cell cycle and
development: redundant roles of cell cycle
regulators Current Opinion in Cell
Biology 1999, 11:655-662.
- excellent recent review on liver
development. (source for references cited
below)
- Weinberg RA:
The retinoblastoma protein and cell cycle
control.
Cell 1995, 81:
323&endash;330.
- Harper JW, Elledge SJ:
Cdk inhibitors in development and
cancer.
Curr Opin Genet Dev 1996, 6:
56&endash;64.
- Geng Y, Eaton EN, Picon M, Roberts JM,
Lundberg AS, Gifford A, Sardet C, Weinberg
RA:
Regulation of cyclin E transcription by E2Fs
and retinoblastoma protein.
Oncogene 1996, 12:
1173&endash;1180.
- Botz J, Zerfass-Thome K, Spitkovsky D,
Delius H, Vogt B, Eilers M, Hatzigeorgiou A,
Jansen-Durr P:
Cell cycle regulation of the murine cyclin E
gene depends on an E2F binding site in the
promoter.
Mol Cell Biol 1996, 16:
3401&endash;3409.
- Ohtani K, DeGregori J, Nevins JR:
Regulation of the cyclin E gene by
transcription factor E2F1.
Proc Natl Acad Sci USA 1995, 92:
12146&endash;12150.
- Dyson N:
The regulation of E2F by pRb-family
proteins.
Genes Dev 1998, 12:
2245&endash;2262.
- Brehm A, Miska EA, McCance DJ, Reid JL,
Bannister AJ, Kouzarides T:
Retinoblastoma protein recruits histone
deacetylase to repress transcription.
Nature 1998, 391:
597&endash;601.
- Luo RX, Postigo AA, Dean DC:
Rb interacts with histone deacetylase to
repress transcription.
Cell 1998, 92:
463&endash;473.
- Magnaghi-Jaulin L, Groisman R, Naguibneva I,
Robin P, Lorain S, Le Villain JP, Troalen F,
Trouche D, Harel-Bellan A:
Retinoblastoma protein represses
transcription by recruiting a histone
deacetylase.
Nature 1998, 391:
601&endash;605.
- Grunstein M:
Histone acetylation in chromatin structure
and transcription.
Nature 1997, 389:
349&endash;352.
- Gu W, Schneider JW, Condorelli G, Kaushal S,
Mahdavi V, Nadal-Ginard B:
Interaction of myogenic factors and the
retinoblastoma protein mediates muscle cell
commitment and differentiation.
Cell 1993, 72:
309&endash;324.
- Novitch BG, Mulligan GJ, Jacks T, Lassar
AB:
Skeletal muscle cells lacking the
retinoblastoma protein display defects in muscle
gene expression and accumulate in S and G2
phases of the cell cycle.
J Cell Biol 1996, 135:
441&endash;456.
- Nead MA, Baglia LA, Antinore MJ, Ludlow JW,
McCance DJ:
Rb binds c-Jun and activates
transcription.
EMBO J 1998, 17:
2342&endash;2352.
- Chen PL, Riley DJ, Chen Y, Lee WH:
Retinoblastoma protein positively regulates
terminal adipocyte differentiation through
direct interaction with C/EBPs.
Genes Dev 1996, 10:
2794&endash;2804.
- Sellers WR, Novitch BG, Miyake S, Heith A,
Otterson GA, Kaye FJ, Lassar AB, Kaelin WG
Jr:
Stable binding to E2F is not required for the
retinoblastoma protein to activate
transcription, promote differentiation, and
suppress tumor cell growth.
Genes Dev 1998, 12:
95&endash;106.
- Dunaief JL, Strober BE, Guha S, Khavari PA,
Alin K, Luban J, Begemann M, Crabtree GR, Goff
SP:
The retinoblastoma protein and BRG1 form a
complex and cooperate to induce cell cycle
arrest.
Cell 1994, 79:
119&endash;130.
- Strober BE, Dunaief JL, Guha , Goff SP:
Functional interactions between the
hBRM/hBRG1 transcriptional activators and the
pRB family of proteins.
Mol Cell Biol 1996, 16:
1576&endash;1583.
- Singh P, Coe J, Hong W:
A role for retinoblastoma protein in
potentiating transcriptional activation by the
glucocorticoid receptor.
Nature 1995, 374:
562&endash;565.
- Shao Z, Ruppert S, Robbins PD:
The retinoblastoma-susceptibility gene
product binds directly to the human TATA-binding
protein-associated factor TAFII250.
Proc Natl Acad Sci USA 1995, 92:
3115&endash;3119.
- Ruppert S, Wang EH, Tjian R:
Cloning and expression of human TAFII250: a
TBP-associated factor implicated in cell-cycle
regulation.
Nature 1993, 362:
175&endash;179.
- Mizzen CA, Yang XJ, Kokubo T, Brownell JE,
Bannister AJ, Owen-Hughes T, Workman J, Wang L,
Berger SL, Kouzarides T et al.:
The TAF(II) 250 subunit of TFIID has histone
acetyltransferase activity.
Cell 1996, 87:
1261&endash;1270.
- Cobrinik D, Lee M-H, Hannon G, Mulligan G,
Bronson RT, Dyson N, Harlow E, Beach D, Weinberg
RA, Jacks T:
Shared role of the pRB-related p130 and p107
proteins in limb development.
Genes Dev 1996, 10:
1633&endash;1644.
- Lee M-H, Williams BO, Mulligan G, Mukai S,
Bronson RT, Dyson N, Harlow E, Jacks T:
Targeted disruption of p107: functional
overlap between p107 and Rb.
Genes Dev 1996, 10:
1621&endash;1632.
- Clarke AR, Maandag ER, van Roon M, van der
Lugt NM, van der Valk M, Hooper ML, Berns A, te
Riele H:
Requirement for a functional Rb-1 gene in
murine development.
Nature 1992, 359:
328&endash;330.
- Jacks T, Fazeli A, Schmitt EM, Bronson RT,
Goodell MA, Weinberg RA:
Effects of an Rb mutation in the
mouse.
Nature 1992, 359:
295&endash;300.
- Lee EY, Chang CY, Hu N, Wang YC, Lai CC,
Herrup K, Lee WH, Bradley A:
Mice deficient for Rb are nonviable and show
defects in neurogenesis and
haematopoiesis.
Nature 1992, 359:
288&endash;294.
- Zacksenhaus E, Jiang Z, Chung D, Marth JD,
Phillips RA, Gallie BL:
pRb controls proliferation, differentiation,
and death of skeletal muscle cells and other
lineages during embryogenesis.
Genes Dev 1996, 10:
3051&endash;3064.
- Tsai KY, Hu Y, Macleod KF, Crowley D,
Yamasaki L, Jacks T:
Mutation of E2F-1 suppresses apoptosis and
inappropriate S phase entry and extends survival
of Rb-deficient mouse embryos.
Mol Cell 1998, 2:
293&endash;304.
- Novitch BG, Spicer DB, Kim PS, Cheung WL,
Lassar AB:
pRb is required for MEF2-dependent gene
expression as well as cell-cycle arrest during
skeletal muscle differentiation.
Curr Biol 1999, 9:
449&endash;459.
- Molkentin JD, Black BL, Martin JF, Olson
EN:
Cooperative activation of muscle gene
expression by MEF2 and myogenic bHLH
proteins.
Cell 1995, 83:
1125&endash;1136.
- Parker SB, Eichele G, Zhang P, Rawls A,
Sands AT, Bradley A, Olson EN, Harper JW,
Elledge SJ:
p53-independent expression of
p21Cip1 in muscle and other
terminally differentiating cells.
Science 1995, 267:
1024&endash;1027.
- Halevy O, Novitch BG, Spicer DB, Skapek SX,
Rhee J, Hannon GJ, Beach D, Lassar AB:
Correlation of terminal cell cycle arrest of
skeletal muscle with induction of p21 by
MyoD.
Science 1995, 267:
1018&endash;1021.
- Guo K, Wang J, Andres V, Smith RC, Walsh
K:
MyoD-induced expression of p21 inhibits
cyclin-dependent kinase activity upon myocyte
terminal differentiation.
Mol Cell Biol 1995, 15:
3823&endash;3829.
- Deng C, Zhang P, Harper JW, Elledge SJ,
Leder P:
Mice lacking p21CIP1/WAF1 undergo
normal development, but are defective in G1
checkpoint control.
Cell 1995, 82:
675&endash;684.
- Brugarolas J, Chandrasekaran C, Gordon JI,
Beach D, Jacks T, Hannon GJ:
Radiation-induced cell cycle arrest
compromised by p21 deficiency.
Nature 1995, 377:
552&endash;557.
- Zhang P, Wong C, Liu D, Finegold M, Harper
JW, Elledge SJ:
p21CIP1 and p57KIP2
control muscle differentiation at the myogenin
step.
Genes Dev 1999, 13:
213&endash;224.
- Matsuoka S, Edwards MC, Bai C, Parker S,
Zhang P, Baldini A, Harper JW, Elledge SJ:
p57KIP2, a structurally distinct
member of the p21CIP1 Cdk inhibitor
family, is a candidate tumor suppressor
gene.
Genes Dev 1995, 9:
650&endash;662.
- Zhang P, Liegeois NJ, Wong C, Finegold M,
Hou H, Thompson JC, Silverman A, Harper JW,
DePinho RA, Elledge SJ:
Altered cell differentiation and
proliferation in mice lacking p57KIP2
indicates a role in Beckwith&endash;Wiedemann
syndrome.
Nature 1997, 387:
151&endash;158.
- Yan Y, Frisen J, Lee MH, Massague J,
Barbacid M:
Ablation of the CDK inhibitor
p57Kip2 results in increased
apoptosis and delayed differentiation during
mouse development.
Genes Dev 1997, 11:
973&endash;983.
- Venuti JM, Morris JH, Vivian JL, Olson EN,
Klein WH:
Myogenin is required for late but not early
aspects of myogenesis during mouse
development.
J Cell Biol 1995, 128:
563&endash;576.
- Schneider JW, Gu W, Zhu L, Mahdavi V,
Nadal-Ginard B:
Reversal of terminal differentiation mediated
by p107 in Rb-/- muscle
cells.
Science 1994, 264:
1467&endash;1471.
- Di Cunto F, Topley G, Calautti E, Hsiao J,
Ong L, Seth PK, Dotto GP:
Inhibitory function of
p21Cip1/WAF1 in differentiation of
primary mouse keratinocytes independent of cell
cycle control.
Science 1998, 280:
1069&endash;1072.
- Zhang JM, Wei Q, Zhao X, Paterson BM:
Coupling of the cell cycle and myogenesis
through the cyclin D1- dependent interaction of
MyoD with Cdk4.
EMBO J 1999, 18:
926&endash;933.
- Morgenbesser SD, Williams BO, Jacks T,
DePinho RA:
p53-dependent apoptosis produced by
Rb-deficiency in the developing mouse
lens.
Nature 1994, 371:
72&endash;74.
- Piatigorsky J:
Lens differentiation in vertebrates. A review
of cellular and molecular features.
Differentiation 1981, 19:
134&endash;153.
- McAvoy JW:
Induction of the eye lens.
Differentiation 1980, 17:
137&endash;149.
- DeGregori J, Leone G, Miron A, Jakoi L,
Nevins J:
Distinct roles for E2F proteins in cell
growth control and apoptosis.
Proc Natl Acad Sci USA 94:
7245&endash;7250.
- Quelle DE, Zindy F, Ashmun RA, Sherr CJ:
Alternative reading frames of the INK4A
tumour supressor gene encode two unrelated
proteins capable of inducing cell cycle
arrest.
Cell 1995, 83:
993&endash;1000.
- Pomerantz J, Schreiber-Agus N, Liegeois NJ,
Silverman A, Alland L, Chin L, Potes J, Chen K,
Orlow I, Lee HW, Cordon-Cardo C, DePinho RA:
The Ink4a tumour suppressor gene product,
p19Arf, interacts with MDM2 and neutralizes
MDM2's inhibition of p53.
Cell 1998, 92:
713&endash;723.
- Zhang Y, Xiong Y, Yarbrough WG:
ARF promotes MDM2 degradation and stabilizes
p53: ARF-INK4a locus deletion impairs both the
Rb and p53 tumour suppression pathways.
Cell 1992, 92:
725&endash;734.
- Zhang P, Wong C, DePinho RA, Harper JW,
Elledge SJ:
Cooperation between the Cdk inhibitors
p27KIP1 and p57KIP2 in the
control of tissue growth and
development.
Genes Dev 1998, 12:
3162&endash;3167.
- Fero ML, Rivkin M, Tasch M, Porter P, Carow
CE, Firpo E, Polyak K, Tsai LH, Broudy V,
Perlmutter RM et al.:
A syndrome of multiorgan hyperplasia with
features of gigantism, tumorigenesis, and female
sterility in p27Kip1-deficient
mice.
Cell 1996, 85:
733&endash;744.
- Kiyokawa H, Kineman RD, Manova-Todorova KO,
Soares VC, Hoffman ES, Ono M, Khanam D, Hayday
AC, Frohman LA, Koff A:
Enhanced growth of mice lacking the
cyclin-dependent kinase inhibitor function of
p27Kip1.
Cell 1996, 85:
721&endash;732.
- Nakayama K, Ishida N, Shirane M, Inomata A,
Inoue T, Shishido N, Horii I, Loh DY:
Mice lacking p27Kip1 display
increased body size, multiple organ hyperplasia,
retinal dysplasia, and pituitary tumors.
Cell 1996, 85:
707&endash;720.
- Franklin DS, Godfrey VL, Lee H, Kovalev GI,
Schoonhoven R, Chen Kiang S, Su L, Xiong Y:
CDK inhibitors p18INK4c and
p27Kip1 mediate two separate pathways
to collaboratively suppress pituitary
tumorigenesis.
Genes Dev 1998, 12:
2899&endash;2911.
- Sherr CJ:
Cancer cell cycles.
Science 1996, 274:
1672&endash;1677.
- Ohtsubo M, Theodoras AM, Schumacher J,
Roberts JM, Pagano M:
Human cyclin E, a nuclear protein essential
for the G1-to-S phase transition.
Mol Cell Biol 1995, 15:
2612&endash;2624.
- Lacey KR, Jackson PK, Stearns T:
Cyclin-dependent kinase control of centrosome
duplication.
Proc Natl Acad Sci USA 1999, 96:
2817&endash;2822.
- Matsumoto Y, Hayashi K, Nishida E:
Cyclin-dependent kinase 2 (Cdk2) is required
for centrosome duplication in mammalian
cells.
Curr Biol 1999, 9:
429&endash;432.
- Hinchcliffe EH, Li C, Thompson EA, Maller
JL, Sluder G:
Requirement of Cdk2-cyclin E activity for
repeated centrosome reproduction in
Xenopus egg extracts.
Science 1999, 283:
851&endash;854.
- Sicinski P, Donaher JL, Parker SB, Li T,
Fazeli A, Gardner H, Haslam SZ, Bronson RT,
Elledge SJ, Weinberg RA:
Cyclin D1 provides a link between development
and oncogenesis in the retina and
breast.
Cell 1995, 82:
621&endash;630.
- Geng Y, Whoriskey W, Park MY, Bronson RT,
Medema RH, Li T, Weinberg RA, Sicinski P:
Rescue of cyclin D1 deficiency by knockin
cyclin E.
Cell 1999, 97:
767&endash;777.
- Draetta GF:
Mammalian G1 cyclins.
Curr Opin Cell Biol 1994, 6:
842&endash;846. Rane SG, Dubus P, Mettus RV,
Galbreath EJ, Boden G, Reddy EP, Barbacid M:
Loss of Cdk4 expression causes
insulin-deficient diabetes and Cdk4 activation
results in beta-islet cell hyperplasia.
Nat Genet 1999, 22: 44&endash;52.
- Sicinski P, Donaher JL, Geng Y, Parker
SB, Gardner H, Park MY, Robker RL, Richards
JS, McGinnis LK, Biggers JD et al.:
Cyclin D2 is an FSH-responsive gene
involved in gonadal cell proliferation and
oncogenesis.
Nature 1996, 384:
470&endash;474.
|
|
Introduction
